Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

WaferGen Biosystems Inc.

www.wafergen.com

Latest From QuatRx Pharmaceuticals Co.

Keeping Track: FDA Approves First Rx DHEA, Receives Applications For Midostaurin, Gesulkumab, Biosimilar Avastin

The latest drug development news and highlights from our FDA Performance Tracker.

Approvals Regulation

Viking sets sail with 5 Ligand assets

Viking Therapeutics licensed five assets from Ligand Pharmaceuticals, including a clinical-stage type 2 diabetes program that the private San Diego-based company has been working on since it was founded in late 2012.

Metabolic Disorders Gastrointestinal

Deals Shaping The Medical Industry, September 2013

Derived from Strategic Transactions, Elsevier Business Intelligence’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing.

BioPharmaceutical Medical Device

Women’s Health: Moving Beyond Gynecology To Sexuality

Big Pharma’s exodus from women’s health has created opportunities for biotech start-ups, which hope to tap into potentially huge markets. Profiles of Evestra Pharmaceuticals, S1 Biopharma, and Sprout Pharmaceuticals.

BioPharmaceutical
See All

Company Information

  • Industry
  • Biotechnology
    • Drug Discovery Tools
      • Bioinformatics
      • Genomics-Proteomics
    • Nanotechnology, Chips, etc.
  • Research, Analytical Equipment & Supplies
    • PCR & Amplification Tools
  • Services
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • WaferGen Inc.
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • WaferGen Biosystems Inc.
  • Senior Management
  • Rolland D Carlson, PhD, Pres. & CEO
    Michael Henighan, CFO
    Maithreyan Srinivasan, PhD, CTO
    Syed Husain, SVP, Engineering
    Jude Dunne, PhD, VP, Product Dev.
    Yong Yi, VP, Marketing
    Andy Moye, VP, Sales
  • Contact Info
  • WaferGen Biosystems Inc.
    Phone: (877) 923-3746
    34700 Campus Dr.
    Fremont, CA 94555
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register